We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Lactate Concentrations Evaluated In Suspected Infections

By LabMedica International staff writers
Posted on 16 Oct 2012
The relationship between blood lactate concentrations categorized into groups and mortality appears to be linear, but the relationship between lactate as a continuous measurement and mortality is uncertain.

The prognostic significance of incremental blood lactate concentrations among emergency department (ED) patients with suspected infection has been evaluated and categorized into low, intermediate, and high groups.

Scientists at the University of Mississippi Medical Center (Jackson, MS, USA) carried out a retrospective cohort analysis of adult ED patients with suspected infection from a large urban ED during January 2007 to May 2011. Over the study period, 2,596 patients met inclusion criteria and the median age was 61 years, the median hospital length of stay was eight days and the overall mortality was 14.4%.

The whole blood lactate measurements were performed in the ED using the i-STAT point-of-care (POC) measurement (Abbott Point of Care Inc.; Princeton, NJ, USA; www.abbottpointofcare.com ). The median initial lactate concentration was 2.1 mmol/L, and 459 (17.6%) subjects had an initial lactate greater than 4 mmol/L. Mortality continued to rise across the continuum of incremental elevations, from 6% for lactate greater than 1.0 mmol/L up to 39% for lactate 19-20 mmol/L. Polynomial regression analysis showed a strong curvilinear correlation between lactate and mortality.

The authors concluded that in ED patients with suspected infection, incremental elevations in whole blood lactate values up to 20 mmol/L are associated with progressive increases in mortality. Clinicians should be aware of the prognostic significance of incremental increases in lactate, even in the significantly elevated range, and should avoid considering all patients with a high lactate to be at similar risk of death. The study was published on August 20, 2012, in the journal Academic Emergency Medicine.

Related Links:
University of Mississippi Medical Center
Abbott Point of Care Inc.



Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Total 25-Hydroxyvitamin D₂ & D₃ Assay
Total 25-Hydroxyvitamin D₂ & D₃ Assay
New
HIV-1 Test
HIV-1 Real Time RT-PCR Kit
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get complete access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: Researcher Kanta Horie places a sample in a mass spectrometer that measures protein levels in blood plasma and other fluids (Photo courtesy of WashU Medicine)

Highly Accurate Blood Test Diagnoses Alzheimer’s and Measures Dementia Progression

Several blood tests are currently available to assist doctors in diagnosing Alzheimer's disease in individuals experiencing cognitive symptoms. However, these tests do not provide insights into the clinical... Read more

Immunology

view channel
Image: The findings were based on patients from the ADAURA clinical trial of the targeted therapy osimertinib for patients with NSCLC with EGFR-activated mutations (Photo courtesy of YSM Multimedia Team)

Post-Treatment Blood Test Could Inform Future Cancer Therapy Decisions

In the ongoing advancement of personalized medicine, a new study has provided evidence supporting the use of a tool that detects cancer-derived molecules in the blood of lung cancer patients years after... Read more

Microbiology

view channel
Image: Schematic representation illustrating the key findings of the study (Photo courtesy of UNIST)

Breakthrough Diagnostic Technology Identifies Bacterial Infections with Almost 100% Accuracy within Three Hours

Rapid and precise identification of pathogenic microbes in patient samples is essential for the effective treatment of acute infectious diseases, such as sepsis. The fluorescence in situ hybridization... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.